Inhibition of lung adenocarcinoma cells by insulin‐like growth factor‐I receptor and Kirsten rat sarcoma mutations: A mutation analysis with antisense oligodeoxynucleotide

Publisher： John Wiley & Sons Inc

E-ISSN： 1759-7714|6|3|260-268

ISSN： 1759-7706

Source： Thoracic Cancer, Vol.6, Iss.3, 2015-05, pp. : 260-268

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the insulin‐like growth factor‐1 receptor by picropodophyllin for lung cancer chemoprevention

By  

Molecular Carcinogenesis, Vol. 54, Iss. S1, 2015-06 ,pp. : E129-E137

John Wiley & Sons Inc

Access to resources Recommend Favorite

Apigenin suppresses insulin‐like growth factor I receptor signaling in human prostate cancer: An in vitro and in vivo study

By  

Molecular Carcinogenesis, Vol. 48, Iss. 3, 2009-03 ,pp. : 243-252

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of bronchoscopic biopsy for the detection of epidermal growth factor receptor mutations and anaplastic lymphoma kinase gene rearrangement in lung adenocarcinoma

By  

Thoracic Cancer, Vol. 6, Iss. 6, 2015-11 ,pp. : 709-714

John Wiley & Sons Inc

Access to resources Recommend Favorite

Blocking transferrin receptor inhibits the growth of lung adenocarcinoma cells in vitro

By  

Thoracic Cancer, Vol. 9, Iss. 2, 2018-02 ,pp. : 253-261

John Wiley & Sons Inc

Access to resources Recommend Favorite

Subsequent treatment of epidermal growth factor receptor‐tyrosine kinase inhibitor failure in patients with advanced lung adenocarcinoma

By  

Thoracic Cancer, Vol. 6, Iss. 6, 2015-11 ,pp. : 678-686

John Wiley & Sons Inc

Access to resources Recommend Favorite